Risk score model for the development of hepatocellular carcinoma in treatment-naïve patients receiving oral antiviral treatment for chronic hepatitis B

BACKGROUND/AIMS: This study aimed to develop and validate a risk prediction model for the development of hepatocellular carcinoma (HCC) in treatment-naïve patients receiving oral antiviral treatment for chronic hepatitis B (CHB). METHODS: We investigated 2,061 Korean treatment-naïve patients with CH...

Descripción completa

Detalles Bibliográficos
Autores principales: Sohn, Won, Cho, Ju-Yeon, Kim, Ji Hoon, Lee, Jung Il, Kim, Hyung Joon, Woo, Min-Ah, Jung, Sin-Ho, Paik, Yong-Han
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Association for the Study of the Liver 2017
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5497662/
https://www.ncbi.nlm.nih.gov/pubmed/28506056
http://dx.doi.org/10.3350/cmh.2016.0086

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5497662/
https://www.ncbi.nlm.nih.gov/pubmed/28506056
http://dx.doi.org/10.3350/cmh.2016.0086

Ejemplares similares